To the full analysis
Perdoceo Education stock: growth
PRDOPerdoceo Education reported $846.1M in revenue for fiscal 2025, up 24.2% on the prior year, up 4.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−3.9%
per year from 2006 to 2025, per share −1.8%
Earnings (Annual rate)
6.7%
per year from 2006 to 2025, per share 9%
Free cash flow (Annual rate)
2.1%
per year from 2006 to 2025, per share 4.2%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 4.2% | 0.0% | −3.9% |
| Revenue per share | 5.7% | 0.4% | −1.8% |
| Earnings | 5.2% | 11.9% | 6.7% |
| Earnings per share | 6.7% | 12.5% | 9.0% |
| Free cash flow | 4.9% | no data | 2.1% |
| Free cash flow per share | 6.4% | no data | 4.2% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $1.79B | $46.57M | $146.92M |
| 2007 | $1.67B | $59.55M | $144.23M |
| 2008 | $1.71B | $60.14M | $132.87M |
| 2009 | $1.84B | $81.22M | $187.83M |
| 2010 | $2.12B | $157.77M | $144.98M |
| 2011 | $1.88B | $18.57M | $152.12M |
| 2012 | $1.49B | −$142.8M | −$54.74M |
| 2013 | $1.06B | −$164.26M | −$105.44M |
| 2014 | $741.36M | −$178.16M | −$131.78M |
| 2015 | $847.27M | $51.89M | −$33.38M |
| 2016 | $704.39M | −$18.71M | $1.78M |
| 2017 | $596.44M | −$31.9M | −$28.12M |
| 2018 | $581.3M | $55.18M | $50.26M |
| 2019 | $627.7M | $69.98M | $67.91M |
| 2020 | $687.31M | $124.26M | $170.19M |
| 2021 | $693.03M | $109.64M | $180.66M |
| 2022 | $695.21M | $95.87M | $135.57M |
| 2023 | $710M | $147.65M | $105.61M |
| 2024 | $681.26M | $147.59M | $156.97M |
| 2025 | $846.1M | $159.91M | $216.66M |
Revenue by segment
How Perdoceo Education Corporation makes its money and how that has shifted. Names are as the company reports them.
- C T U$461.6M55%
- A I U.S.$226.2M27%
- University of St. Augustine for Health Sciences, LLC$157.6M19%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| C T U | $461.6M | 54.6% |
| A I U.S. | $226.22M | 26.7% |
| University of St. Augustine for Health Sciences, LLC | $157.57M | 18.6% |
| Total revenue | $846.1M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.